U.S. flag

An official website of the United States government

NM_007272.3(CTRC):c.640-12G>A AND Hereditary pancreatitis

Germline classification:
Conflicting interpretations of pathogenicity (4 submissions)
Last evaluated:
Jan 17, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000507043.20

Allele description [Variation Report for NM_007272.3(CTRC):c.640-12G>A]

NM_007272.3(CTRC):c.640-12G>A

Gene:
CTRC:chymotrypsin C [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.21
Genomic location:
Preferred name:
NM_007272.3(CTRC):c.640-12G>A
HGVS:
  • NC_000001.11:g.15445585G>A
  • NG_009253.1:g.12143G>A
  • NM_007272.3:c.640-12G>AMANE SELECT
  • NC_000001.10:g.15772080G>A
  • NM_007272.2:c.640-12G>A
Links:
dbSNP: rs183053579
NCBI 1000 Genomes Browser:
rs183053579
Molecular consequence:
  • NM_007272.3:c.640-12G>A - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Hereditary pancreatitis (PCTT)
Synonyms:
Hereditary chronic pancreatitis
Identifiers:
MONDO: MONDO:0008185; MedGen: C0238339; Orphanet: 676; OMIM: 167800

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000603264ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process 2021)
Likely pathogenic
(Oct 21, 2022)
germlineclinical testing

Citation Link,

SCV002486560Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Jan 17, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002537668Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Uncertain significance
(Apr 23, 2021)
germlinecuration

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV002658536Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Apr 16, 2015)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Early-Onset Acute Recurrent and Chronic Pancreatitis Is Associated with PRSS1 or CTRC Gene Mutations.

Giefer MJ, Lowe ME, Werlin SL, Zimmerman B, Wilschanski M, Troendle D, Schwarzenberg SJ, Pohl JF, Palermo J, Ooi CY, Morinville VD, Lin TK, Husain SZ, Himes R, Heyman MB, Gonska T, Gariepy CE, Freedman SD, Fishman DS, Bellin MD, Barth B, Abu-El-Haija M, et al.

J Pediatr. 2017 Jul;186:95-100. doi: 10.1016/j.jpeds.2017.03.063. Epub 2017 May 10. Erratum in: J Pediatr. 2018 Dec;203:468-469. doi: 10.1016/j.jpeds.2018.08.026.

PubMed [citation]
PMID:
28502372
PMCID:
PMC5506853
See all PubMed Citations (4)

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV000603264.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The CTRC c.640-12G>A variant (rs183053579) is reported in the literature in multiple individuals affected with pancreatitis (Giefer 2017, LaRusch 2015, Masson 2015). Functional characterization of patient mRNA indicates that the variant leads to the inclusion of 10 nucleotides from intron 6, potentially introducing a frameshift in the translated protein (Masson 2015). This variant is reported in ClinVar (Variation ID: 439575), and is found in the African population with an allele frequency of 0.65% (162/24,920 alleles, including a single homozygote) in the Genome Aggregation Database. This is an intronic variant in a weakly conserved nucleotide, but computational analyses (Alamut v.2.11) predict that this variant may impact splicing by creating a novel cryptic acceptor splice site, consistent with the functional studies. Based on available information, the c.640-12G>A variant is considered to be likely pathogenic. References: Giefer MJ et al. Early-Onset Acute Recurrent and Chronic Pancreatitis Is Associated with PRSS1 or CTRC Gene Mutations. J Pediatr. 2017 Jul;186:95-100. PMID: 28502372. LaRusch J et al. The Common Chymotrypsinogen C (CTRC) Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population. Clin Transl Gastroenterol. 2015 Jan 8;6:e68. PMID: 25569187. Masson E et al. Report of 2 CTRC Intronic Mutations Associated With Acute or Chronic Pancreatitis and Delineation of Their Pathogenic Molecular Mechanisms. Pancreas. 2015; 44(6):999-1001. PMID: 26166474.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002486560.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Sema4, Sema4, SCV002537668.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Ambry Genetics, SCV002658536.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The c.640-12G>A intronic variant results from a G to A substitution 12 nucleotides upstream from coding exon 7 in the CTRC gene. This variant was identified in several individuals with pancreatitis, including three from different African countries (LaRusch J et al. Clin Transl Gastroenterol, 2015 Jan;6:e68; Masson E et al. Pancreas, 2015 Aug;44:999-1001). In one individual, RT-PCR and sequencing of cultured fibroblasts demonstrated aberrant splicing leading to the creation of a novel splice acceptor, resulting in inclusion of the last 10 bp of the intron, and leading to a protein elongation (Masson E et al. Pancreas, 2015 Aug;44:999-1001). Based on data from gnomAD, the A allele has an overall frequency of 0.0698% (197/282392) total alleles studied, including 1 homozygote. The highest observed frequency was 0.6501% (162/24920) of African alleles. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice acceptor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024